PRESTIGE CONSUMER HEALTHCARE INC. Decrease in Unrecognized Tax Benefits is Reasonably Possible
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $200.00 thousand as of 2025-03-31, per its 10-K filed 2025-05-09.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2025-05-09
- 2025-03-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $200.00K.
- 2024-03-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $2.60M.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible |
|---|---|
| 2025-03-31 | $200.00K 10-K · filed 2025-05-09 |
| 2024-03-31 | $2.60M 10-K · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |